Insider Buying: HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Buys 477 Shares of Stock

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank purchased 477 shares of the business’s stock in a transaction on Friday, January 13th. The stock was purchased at an average cost of $23.29 per share, for a total transaction of $11,109.33. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

HCA Healthcare Stock Performance

Shares of HCA opened at $342.25 on Friday. The business has a 50-day simple moving average of $324.53 and a two-hundred day simple moving average of $341.25. The stock has a market cap of $84.26 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the firm earned $5.90 earnings per share. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.84%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of HCA. Sanders Capital LLC boosted its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock valued at $3,498,417,000 after purchasing an additional 116,826 shares during the last quarter. First Eagle Investment Management LLC grew its holdings in HCA Healthcare by 0.5% during the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock valued at $1,351,830,000 after buying an additional 23,177 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of HCA Healthcare by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock valued at $1,159,882,000 after acquiring an additional 50,321 shares during the last quarter. Capital World Investors raised its stake in HCA Healthcare by 0.7% during the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock valued at $878,975,000 after purchasing an additional 19,121 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $840,286,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Royal Bank of Canada decreased their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. KeyCorp dropped their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Barclays lowered their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.